Copyright
©The Author(s) 2003.
World J Gastroenterol. Jun 15, 2003; 9(6): 1241-1245
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1241
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1241
Figure 5 p53 protein level by Western blot assay.
They were detected after 24 h of treatment. A, B, C, D were respectively normal control, TRAIL (100 μg•l-1), doxorubicin (0.86 μmol•l-1) and TRAIL (100 μg•l-1) + doxorubicin (0.86 μmol•l-1) groups. There was no difference in p53 protein expression among these four groups (P > 0.05).
- Citation: Xu LH, Deng CS, Zhu YQ, Liu SQ, Liu DZ. Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480. World J Gastroenterol 2003; 9(6): 1241-1245
- URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1241.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1241